Qiagen NV
(WBO:QGE2)
€
40.8
-0.54 (-1.31%)
Market Cap: 9.01 Bil
Enterprise Value: 9.48 Bil
PE Ratio: 137.61
PB Ratio: 2.86
GF Score: 87/100 
Qiagen NV at Stifel Healthcare Conference Transcript
Nov 14, 2023 / 04:30PM GMT
Release Date Price:
€37.53
(+1.45%)
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Okay everybody. Welcome back to the 2023 Stifel Healthcare Conference on the Life Sciences and Diagnostics track here, and I'm happy to have CEO, Thierry Bernard from QIAGEN with us. Thierry thanks for joining us.
Thierry Bernard
Qiagen N.V. - CEO, MD & Member of Management Board
Good morning. Thank you.
Questions & Answers
Daniel Anthony Arias;Thierry Bernard
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst;Qiagen N.V. - CEO, MD & Member of
Our pleasure. Maybe a place to start, which I've been doing with some of our companies here is just sort of recap the last quarter, 5% CER growth for the nonbusiness this quarter was outside of 1 or 2 players, the highest in the core tools group, I think it's worth noting. Can you just maybe talk where the relative strength in the business is today on the non-COVID side?
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers